Boehringer Ingelheim International Gmbh

Louis Morency

Martin Duplessis

Clint A James

Claudio F Sturino

Patrick Deroy

Jean-Eric Lacoste

Martin Tremblay

Sébastien Morin

Joannie Minville

Pierre Louis Beaulieu

Christiane Yoakim

Bruno Simoneau

Teddy Halmos

Anne-Marie Faucher

James Gillard

Lee Fader

Carl Thibeault

Paul John Edwards

Sebastien Morin

Mathieu Parisien

Eric Malenfant

Claudio Sturino

Paul J Edwards

Compounds of formula (I) and pharmaceutical compositions thereof: wherein AAand Aare each independently selected from the group consisting of N and CR, wherein Ris an optionally substituted heterocyclyl or an optionally substituted &#x2014;(C)alkyl-heterocyclyl, Ris an optionally substituted aryl or an optionally subsisted heteroaryl, Ris an optionally substituted aryl, an optionally substituted heterocyclyl or an optionally substituted heteroaryl, useful as an inhibitor of HIV replication. 

Inhibitors of HIV replication

Compounds of Formula (I) wherein n, R, R, R, Rand Z are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection. 

Inhibitors of cytomegalovirus

Compounds of formula (I): wherein R, R, A, A, A, A, X and Y are as defined herein, are useful as inhibitors of HIV replication.

Growing community of inventors

Montréal, Canada

Louis Morency